Angela Fitch,MD (@drangelafitch) 's Twitter Profile
Angela Fitch,MD

@drangelafitch

Founder/Chief Medical Officer
knownwell
President Obesity Medicine Association#obesitymedicine Internal medicine/ Pediatric physician, educator and advocate

ID: 1099916594

linkhttp://Www.knownwell.co calendar_today18-01-2013 03:28:33

1,1K Tweet

1,1K Followers

638 Following

Angela Fitch,MD (@drangelafitch) 's Twitter Profile Photo

I am so grateful for this opportunity to volunteer to help lead the OAC coalition in this important and exciting time for the disease of obesity!

Angela Fitch,MD (@drangelafitch) 's Twitter Profile Photo

This is a great article and we need to highlight this more to protect patients from potentially harmful treatment of a disease that doesn’t have comprehensive universal coverage.

TJ Parker⚡️ (@tjparker) 's Twitter Profile Photo

Imagine shamelessly stealing IP, compounding their drugs (which results in patient harm time and time again), selling your fraudulent product for roughly the same net-price as the original inventor, and then painting them as the problem in a fucking Super Bowl commercial.

Jen Silverman (@speakjen) 's Twitter Profile Photo

Great video shoot 📹 with amazing expert faculty Jaime Almandoz, MD MBA FTOS, Angela Fitch,MD & Carolynn Francavilla who discuss strategies to overcome barriers in #ObesityCare. Stay tuned and follow PeerView for the final educational initiative. 🩺 #MedEd #PeerView

Great video shoot 📹 with amazing expert faculty
<a href="/JaimeAlmandoz/">Jaime Almandoz, MD MBA FTOS</a>, <a href="/DrAngelaFitch/">Angela Fitch,MD</a> &amp; <a href="/Dr_Francavilla/">Carolynn Francavilla</a> who discuss strategies to overcome barriers in #ObesityCare. Stay tuned and follow <a href="/PeerView/">PeerView</a> for the final educational initiative. 🩺 #MedEd #PeerView
Karl Nadolsky (@drkarlnadolsky) 's Twitter Profile Photo

The study revealed the increased likelihood of being diagnosed with low-risk thyroid cancer after treatment with GLP-1 RAs — not because GLP-1 RAs cause thyroid cancer but because they are more likely to be diagnosed with it because clinicians are more likely to look for it 🤦🏼

Angela Fitch,MD (@drangelafitch) 's Twitter Profile Photo

Thank you Eli Lilly and Company for innovation on care delivery by providing access to the vial program. Now at a lower price (would have liked lower but 🙏 for a future of lower yet) and more dosing options! investor.lilly.com/news-releases/…

Angela Fitch,MD (@drangelafitch) 's Twitter Profile Photo

This is so true. Yet in obesity treatment we are letting the perfect be the enemy of good and we don’t consistently promote body composition measures with BIA which is clinically the easiest thing to incorporate yet we keep saying it isn’t accurate yet 97% as good as DEXA.

OAC (@obesityaction) 's Twitter Profile Photo

The phase-out of compounded GLP-1s has left many patients asking: What now? In this episode of Fresh Perspectives, OAC President & CEO Joe Nadglowski talks with obesity medicine expert Dr. Angela Fitch about: 🔹 Why compounded GLP-1s are no longer available 🔹 Safe, effective

The phase-out of compounded GLP-1s has left many patients asking: What now? In this episode of Fresh Perspectives, OAC President &amp; CEO Joe Nadglowski talks with obesity medicine expert Dr. Angela Fitch about:

 🔹 Why compounded GLP-1s are no longer available
 🔹 Safe, effective
OAC (@obesityaction) 's Twitter Profile Photo

Thank you, U.S. Senator John Fetterman, for bravely sharing your story and urging the current administration to expand access to obesity medications. “It should be simple: Our government should be in the business of making lifesaving medication accessible and affordable.”

Thank you, U.S. Senator John Fetterman, for bravely sharing your story and urging the current administration to expand access to obesity medications.

“It should be simple: Our government should be in the business of making lifesaving medication accessible and affordable.”
John David Scott MD (@jdscottmd) 's Twitter Profile Photo

ASMBS in two weeks, the AMA will be hosting its annual meeting. If you know anyone in your state delegation to the AMA, please ask to support Res 427, which would obesity as a strategic objective of the AMA. This would greatly enhance our lobbying and advocacy efforts

Neil Floch MD (@neilflochmd) 's Twitter Profile Photo

Is #NOVOMAN going to save the day? Novo Nordisk Will our SUPERHERO rescue patients with obesity by providing affordable access to weightloss medications? Drop prices and increase access to care! Match the #US cost of GLP-1 medications to other countries! #BETHEHERO

Is #NOVOMAN going to save the day? <a href="/novonordisk/">Novo Nordisk</a> 

Will our SUPERHERO rescue patients with obesity by providing affordable access to weightloss medications? 

Drop prices and increase access to care!

Match the #US cost of GLP-1 medications to other countries!

#BETHEHERO
Cardiovascular, Renal, Metabolic, Liver & Obesity (@caremelo_conf) 's Twitter Profile Photo

🤩 Mark your calendars for the next #UNLOKall Webinar: Pharmacological Advances & Case-Based Insights in Obesity Care for PCPs! 📆Monday, 30 Jun 🕙4 PM CEST 🧑‍⚕️Dr. Baruch Itzhak, Angela Fitch,MD and.Josep Vilaseca REGISTER NOW: bit.ly/447cOMb 👈 #CaReMeLO2025

🤩 Mark your calendars for the next #UNLOKall Webinar: Pharmacological Advances &amp; Case-Based Insights in Obesity Care for PCPs! 
📆Monday, 30 Jun
🕙4 PM CEST 
🧑‍⚕️Dr. Baruch Itzhak, <a href="/DrAngelaFitch/">Angela Fitch,MD</a> and.<a href="/josep_vilaseca/">Josep Vilaseca</a> 
 
REGISTER NOW: bit.ly/447cOMb  👈 

#CaReMeLO2025